Key Takeaways
- Gurugram launch resets the growth trajectory: 75% of units sold within 60-65 days, a velocity that dwarfs Dehradun and Noida, and materially lifted consolidated revenue 48% QoQ.
- Residences is now the near-term earnings engine: Higher development management fees from Gurugram drove the bulk of the INR 12.3 crores sequential revenue jump and pulled consolidated EBITDA loss down from INR 21.5 crores to INR 15.7 crores.
- Care Homes turned the corner on contribution margin: Gurgaon Care Home swung from negative 1% to positive 18% margin on 65% occupancy and 5% ARPB growth, while the Memory Care Home also turned positive, together moving from a 15% loss to a profit pool.
- AGEasy is scaling fast but from a small base: Monthly revenue rate jumped from INR 52 lakhs to INR 1.39 crores, with 10 products among Amazon's top 10 best sellers, though the China sourcing pivot to lift margins to 20-25% is still early.
- What to watch next quarter: The November RERA hearing on Noida Phase 2, the pace of Gurgaon Care Home occupancy recovery post-Diwali, and whether the Chandigarh diligence converts into a signed project.
Residences: The Gurugram Inflection
- Sales velocity unprecedented for the company: 214 units sold in ~60 days versus 197 units in Dehradun over several years and 340 in Noida over 2.5 years, with the monthly run rate still climbing month-on-month.
- Pricing power in Gurugram: The market's higher price points make Gurugram a much better financial deal than prior projects, and Phase 2, now being explored, would be sweeter still given the overwhelming response.
- Revenue model has three layers: Upfront development management fees (the current driver), an additional profit-linked fee at project end (unquantified today), and a perpetual annuity stream from operating the community once residents move in.
- Noida Phase 1 on track: Block work completed for all towers, finishing and interiors underway, collections ahead of plan.
- Noida Phase 2 delayed by RERA: A temporary setback with the next hearing in November, but a recent High Court ruling that RERA cannot reject an application after 30 days of silence should strengthen Max India's legal case. The silver lining: market improvement means higher sales realization when Phase 2 eventually launches.
- Bangalore project stalled, Plan B active: The landowner's lender was unwilling to offer flexibility on financial closure, so the deal is effectively on hold; the company is now in talks with other developers for an alternative site.
- Chandigarh in advanced diligence: A deep market study is underway; the market trades around INR 8,500-9,000 per sq ft but Max India expects to price well above that on brand and senior-specific facilities, with a minimum 20% IRR hurdle.
Rajit Mehta: "I was just reflecting in the morning that we had taken some years to sell 197 units in Dehradun, 2.5 years to sell 340 in Noida. And now in Gurgaon, within 60 days, about 214 sales already recorded."
Care Homes: The Margin Inflection
- Contribution margin turned positive: Existing Care Homes reported a positive contribution margin in Q2 FY25 versus a negative 15% margin in Q2 FY24, driven by both the Gurgaon Care Home and the Memory Care Home.
- Gurgaon Care Home swung sharply: Margins moved from minus 1% to plus 18% on the back of 65% occupancy and 5% average revenue per bed growth, though occupancy dipped temporarily due to resident deaths and some move-outs, with recovery expected after Diwali.
- 600-bed target by March 2025 within reach: 234 beds already added (total ~300), 170 LOIs signed in Chennai, 80 additional beds planned for Whitefield (~550 total), plus 50 more beds to be added in either Chennai or Bangalore.
- Dehradun operations breaking even ahead of plan: The INR 6.2 crores in revenue is purely maintenance and services, excluding any marketing fee, and the operation is on track to break even much earlier than originally scheduled.
AGEasy & the D2C Health Stack
- Revenue scaling rapidly: Monthly revenue rate grew from INR 52 lakhs to INR 1.39 crores in September, with 70% coming from marketplaces, 20% from D2C, and 10% offline.
- Marketplace traction is real: 10 products rank among Amazon's top 10 best sellers in their categories, and the offline med-care products business was merged into AGEasy in April 2024 to capture warehouse, logistics and operational synergies.
- Product portfolio expanding: 50 new products launched in H2 for joint pain management, a fall-detection smartwatch (Protech) launched in August and gradually picking up, and a Lung Care condition added in H1 FY25 covering respiratory disorders, designed with input from Dr. Randeep Guleria, ex-Director of AIIMS.
- Gut Health condition coming in Q4 FY25, rounding out a portfolio that now spans Joint Pain, Fall Detection & Prevention, and Lung Care.
- China sourcing pivot for margin: An initial INR 2 crores order for 20 products has been placed, targeting 20-25% margins versus current levels; once the supply chain stabilizes, more products will shift to China sourcing.
- Strategic partnerships in the pipeline: The company is in dialogue with a leading consumer electronics brand to become the technology provider for watches and devices for seniors, with an announcement expected once the deal is signed.
- MoU with IIT Delhi signed to design and customize products for seniors, especially mobility solutions, and a collaboration with Dementia India Alliance and NIMHANS is building protocols and training content.
Rajit Mehta: "There was this one lady from J&K, who could not undertake a knee surgery because of her cardiac condition. She consulted with us; we offered her adjuster brace for one leg. And after experiencing improved mobility, she also ordered one for the right leg. And now the feedback from her is it has restored her independence and improved her quality of life."
Financials: Revenue Jump, Loss Narrowing
- Consolidated revenue grew 48% QoQ to INR 48 crores, primarily driven by higher development management fees from the Gurugram launch, validating management's earlier signal that revenue dips were temporary.
- EBITDA loss narrowed from INR 21.5 crores to INR 15.7 crores on higher residence revenue, cost optimization, and healthy treasury income.
- Finance costs rose YoY due to a new corporate office lease (bifurcated between finance cost and depreciation under Ind-AS) and long-term Care Home leases.
- Dehradun resale mechanics: When residents move out, the company reverses the old lease and books a new one; the INR 1.8 crores reported is the net figure after paying the lease premium cost to the outgoing lessee.
Competitive Positioning & Model Choices
- Ashiana Housing is not a direct competitor: Management drew a clear line: Ashiana operates in the affordable senior living segment (INR 50 lakhs to INR 1 crore) while Antara targets the upper middle class (INR 1 crore to INR 7 crores), so the two do not overlap meaningfully.
- Intergenerational communities are an experiment, not a pivot: The company will wait to see how the Gurugram intergenerational community operates before committing to more, and remains open to partners who want to build intergenerational projects, but is equally happy to pursue both models depending on market and need.
- The 0.15 crore square feet annual development target stands: The Chandigarh opportunity, if signed, would help meet this target, and management affirmed it is not under dispute.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Care Home beds operational | 600 beds (234 added, ~300 total; 170 LOIs in Chennai; 80 more in Whitefield; 50 more in Chennai or Bangalore) | By March 2025 |
| New condition launch | Gut Health condition added to AGEasy portfolio | Q4 FY25 |
| Noida Phase 2 RERA resolution | Next hearing; High Court precedent supports deemed approval after 30 days of RERA silence | November 2024 hearing |
| China sourcing margin lift | 20-25% margins on China-sourced products vs current levels; INR 2 crores initial order placed | Once supply chain stabilizes |
| Long-term aspiration | INR 1,000 crores+ top line, 15-20% PAT margin, break even | 5 years (break even FY27/FY28) |
| March exit rate (ex-AGEasy) | Approximately INR 100 crores | March 2025 exit rate |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Consolidated revenue | ₹48 cr, +48% QoQ |
| Consolidated EBITDA loss | ₹15.7 cr, improved from ₹21.5 cr loss in Q1 |
| Consolidated net worth | ₹445 cr as of Sep 24 |
| Treasury and monetizable assets | ₹370 cr+ as of Sep 24 |
| Antara Assisted Care net revenue | ₹12.6 cr, +26% QoQ and +139% YoY |
| Care Homes net revenue | ₹1.7 cr, +9% QoQ and +29% YoY |
| Care at Home revenue | ₹4.3 cr, highest ever, +15% QoQ and +109% YoY |
| AGEasy net revenue | ₹6.6 cr, highest ever, +40% QoQ and +255% YoY |
| AGEasy monthly revenue run-rate | ₹1.39 cr in Sep 24, up from ₹52 lakhs in Jun 24 |
| AGEasy annual revenue trajectory | ~₹25 cr+, 70% marketplaces, 20% D2C, 10% offline |
| Dehradun operational revenue | ₹6.2 cr, +23% QoQ |
| Dehradun community cash surplus | ~₹115 cr |
| Noida Phase 1 total collections | ₹358 cr, 98% collection efficiency, +10% YoY |
| Gurugram project sales collection | ₹107 cr, 214 of 292 apartments sold by Sep 30 |
| Gurugram performance deposit | ~₹33 cr |
| Antara Assisted Care beds operational | 300 beds, 234 added in Q2 |
| Antara Assisted Care beds target by Mar 25 | 600 beds, 550 LOIs signed or added |
| Gurgaon Care Home occupancy | 65% |
| Gurgaon Care Home contribution margin | 18%, improved from -1% in Q2 FY24 |
| Care at Home contribution margin (NCR) | 22% |
| AGEasy lives touched | 82,711, 13,500 via D2C, 2,100 repeat customers |
| Care at Home lives touched since inception | 17,300 |
| Customer satisfaction: Care Homes | 92% |
| Customer satisfaction: Care at Home | 95% |
| Customer satisfaction: AGEasy | 83% |
| Customer satisfaction: Dehradun community | 88% |
| Resale units in Dehradun (H1 FY25) | 9 units, ₹1.8 cr net marketing fees |
| AGEasy products among Amazon top 10 sellers | 10 products |
| New AGEasy products launched in H2 | 50 products |
| China sourcing order placed | ₹2 cr for 20 products, expected margin improvement to 20-25% |
| Chandigarh market pricing indication | ₹8,500-9,000 per sq ft, company expects to price above |
| Long-term revenue aspiration | ₹1,000 cr+ top line in 5 years, 15-20% PAT, breakeven FY27/FY28 |